Ameritas Investment Partners, Inc. Karyopharm Therapeutics Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	BUY	$16.6 - $25.25 $14,209 - $21,614	856 Added 16.04%	6,194 $117,000
Q1 2020 May 13, 2020	BUY	$14.38 - $27.72 $6,499 - $12,529	452 Added 9.25%	5,338 $103,000
Q3 2019 Nov 14, 2019	BUY	$5.66 - $11.85 $4,907 - $10,273	867 Added 21.57%	4,886 $47,000
Q2 2018 Aug 13, 2018	BUY	$12.0 - $19.88 $12,624 - $20,913	1,052 Added 35.46%	4,019 $68,000
Q2 2017 Aug 15, 2017	BUY	N/A	2,967	2,967 $27,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $62.2M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.